Niagen Bioscience, Inc. (NAGE)

NASDAQ: NAGE · Real-Time Price · USD

4.840

-0.120 (-2.42%)

At close: Apr 28, 2026, 4:00 PM EDT

4.800

-0.040 (-0.83%)

After-hours: Apr 28, 2026, 7:57 PM EDT

Niagen Bioscience Market Cap

Niagen Bioscience has a market cap or net worth of $388.40 million as of April 28, 2026. Its market cap has decreased by -11.89% in one year.

Market Cap

388.40M

Enterprise Value

326.58M

1-Year Change

-11.89%

Ranking

#3274

Market Cap Chart

Since June 25, 2008, Niagen Bioscience's market cap has decreased from $909.70M to $388.40M, a decrease of -57.30%. That is a compound annual growth rate of -4.66%.

Market Cap History

Date	Market Cap	% Change
Apr 27, 2026	397.20M	-21.75%
Dec 31, 2025	507.60M	25.27%
Dec 31, 2024	405.20M	277.28%
Dec 29, 2023	107.40M	-14.15%
Dec 30, 2022	125.10M	-51.02%
Dec 31, 2021	255.40M	-13.89%
Dec 31, 2020	296.60M	15.50%
Dec 31, 2019	256.80M	35.87%
Dec 31, 2018	189.00M	-33.29%
Dec 29, 2017	283.30M	125.74%
Dec 30, 2016	125.50M	-5.71%
Dec 31, 2015	133.10M	41.45%
Dec 31, 2014	94.10M	-40.97%
Dec 31, 2013	159.40M	224.64%
Dec 31, 2012	49.10M	19.76%
Dec 30, 2011	41.00M	-49.88%
Dec 31, 2010	81.80M	544.09%
Dec 31, 2009	12.70M	-95.35%
Dec 31, 2008	272.90M	-70.00%

View and export this data all the way back to 2008. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Armata Pharmaceuticals	402.23M
Invivyd	401.58M
Neumora Therapeutics	400.09M
Century Therapeutics	397.93M
Enanta Pharmaceuticals	392.63M
Autolus Therapeutics	392.56M
Lineage Cell Therapeutics	389.82M
Puma Biotechnology	388.70M

Market Cap Rankings